Price
No data yet.
Social Signal Score
Analyst Ratings
4 analystsRevenue
$3.36M+108.24%Company Profile
- CEO
- Sean Mackay
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 290
- Beta
- 0.00
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -4.98
Financials
Revenue
$3.36M+108.2%Net Income
$-34.72MEBITDA
$-30.64MFree Cash Flow
$-15.74MEPS (diluted)
$-0.88Shares Outstanding (diluted)
39.32M+1727.0%Operating Expenses
$24.00MCash & Debt
$37.47MReturn of Capital
$0.00Revenue by Segment (annual)
$16.76MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2022 | $16.76M | $-115.50M | $-2.94 |
| 2021 | $17.26M | $-83.56M | $-8.16 |
| 2020 | $10.39M | $-23.29M | $-0.60 |
| 2019 | $7.50M | $-13.63M | $-0.35 |
Valuation
ISOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (7)
- Newsglobenewswire.com·12d ago·Neutral
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October BERKELEY, CA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensor technologies today announced that the Company has received a positive decision from GMED regarding certification of its quality management system to ISO 13485. GMED is a notified body designated under the European Union Medica…
View source ↗ - Newsglobenewswire.com·19d ago·Negative
ISO New England selects Eversource's joint transmission project as preferred long-term solution to enhance reliability and affordability MANCHESTER, N.H., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Eversource today announced ISO New England's (ISO-NE) selection of the company's joint Transmission Initiative Down East (TIDE) project as the preferred longer-term transmission solution to meet regional needs outlined by ISO-NE in its competitive transmission solicitation process.
View source ↗ - Newsprnewswire.com·27d ago·Neutral
Silicon Motion Earns ISO/SAE 21434 Automotive Cybersecurity Process Certification Certification validates that the company's automotive cybersecurity engineering and management processes meet internationally recognized requirements TAIPEI and MILPITAS, Calif., Sept. 9, 2026 /PRNewswire/ -- Silicon Motion Technology Corporation (NasdaqGS: SIMO), a global leader in designing and marketing NAND flash controllers for solid-state storage devices, today announced that it has earned ISO/SAE 21434:2021 …
View source ↗ - Newsglobenewswire.com·47d ago·Negative
NAPC Defense Completes Key ISO, Cybersecurity and Secure-Network Qualifications Required for U.S. Government Prime Contractors CLEARWATER, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- NAPC Defense, Inc. (OTCID: NAPD) (“NAPC Defense” or the “Company”), a U.S.-licensed defense manufacturer with exclusive rights to produce and distribute the CornerShot® USA system, today announced the completion of a series of important quality, cybersecurity and secure-network compliance requirements supporting its U.S…
View source ↗ - Newsaccessnewswire.com·49d ago·Neutral
RMTG Expands Cellgenic's Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms An owned-infrastructure investment adds manufacturing, quality-systems, and product-development capacity to support Cellgenic's growing international product portfolio. MIAMI, FL / ACCESS Newswire / August 18, 2026 / Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, …
View source ↗ - Newsglobenewswire.com·50d ago·Negative
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification Recertification aligns with the FDA's newly amended Quality Management System Regulation and supports the Company's regulatory strategy as it pursues FDA clearance Recertification aligns with the FDA's newly amended Quality Management System Regulation and supports the Company's regulatory strategy as it pursues FDA clearance
View source ↗ - Newsaccessnewswire.com·56d ago·Neutral
AI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification Quality Management System Certification Strengthens NeuralCloud's Regulatory Readiness for ECG Software-as-a-Medical-Device Platform TORONTO, ON / ACCESS Newswire / August 11, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company advancing artificial intelligence and neural-network-based technologies for digital health, is pleased to announce that its wholly owne
View source ↗
Earnings
Typical surprise -70.4% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Mar 2$-0.84 vs $-0.39miss
- Thu, Nov 10$-0.47 vs $-0.43miss
- Wed, Aug 10$-0.65 vs $-0.54miss
- Wed, May 11$-0.74 vs $-0.59miss
- Wed, Mar 2$-1.69 vs $-0.68miss
- Wed, Nov 10$-10.66 vs $-0.79miss
Estimates and results for ISO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ISO officers and directors.
- Bought
- $27.9m
- Sold
- —
7 trades
0 trades
- Shamir Nachumbought
- Shamir Nachumbought
- Strahley Johnbought
- Mackay Seanbought
- Rew Richard W. Iibought
- Perceptive Advisors Llcbought
- Northpond Capital Gp, Llcbought
93 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ISO.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.